Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Related Citations for PubMed (Select 23602186)

1.

Docetaxel and permanent alopecia.

Tosti A, Palamaras I, Miteva M, Misciali C.

J Am Acad Dermatol. 2013 May;68(5):e151. doi: 10.1016/j.jaad.2010.06.064. No abstract available.

PMID:
23602186
2.

Permanent chemotherapy-induced alopecia: histopathologic criteria still to be defined.

Tallon B, Blanchard E, Goldberg LJ.

J Am Acad Dermatol. 2013 May;68(5):e151-2. doi: 10.1016/j.jaad.2010.07.019. No abstract available.

PMID:
23602187
3.

Permanent chemotherapy-induced alopecia: case report and review of the literature.

Tallon B, Blanchard E, Goldberg LJ.

J Am Acad Dermatol. 2010 Aug;63(2):333-6. doi: 10.1016/j.jaad.2009.06.063. Epub 2010 May 14. Review.

PMID:
20471136
4.

Docetaxel/Cyclophosphamide-induced ultraviolet recall dermatitis.

Basile FG, Creamer S.

J Clin Oncol. 2011 Dec 1;29(34):e840-1. doi: 10.1200/JCO.2011.37.3779. Epub 2011 Oct 24. No abstract available.

5.

Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients.

Kluger N, Jacot W, Frouin E, Rigau V, Poujol S, Dereure O, Guillot B, Romieu G, Bessis D.

Ann Oncol. 2012 Nov;23(11):2879-84. doi: 10.1093/annonc/mds095. Epub 2012 May 9.

6.

Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.

Tollenaar RA, Liefers GJ, Repelaer van Driel OJ, van de Velde CJ.

Eur J Cancer. 1994;30A(10):1448-53. Review.

PMID:
7833100
7.

[Docetaxel plus carboplatin versus EC-T as adjuvant chemotherapy for triple-negative breast cancer: safety data from a phase III randomized open-label trial].

Yuan P, Xu BH, Wang JY, Ma F, Li Q, Zhang P, Fan Y, Li Q, Wang WM.

Zhonghua Zhong Liu Za Zhi. 2012 Jun;34(6):465-8. doi: 10. 3760/cma.j.issn.0253-3766.2012.06.014. Chinese.

PMID:
22967451
8.

Cognitive impairment with significant brain parenchymal volume loss following standard adjuvant chemotherapy in a patient with breast cancer.

Swayampakula AK, Alkhouri N, Haut MW, Abraham J.

Clin Adv Hematol Oncol. 2007 Dec;5(12):985-7; discussion 987-8. Review. No abstract available.

PMID:
18277960
9.

[Adjuvant!Online--an Internet-based decision tool for adjuvant chemotherapy in early breast cancer].

Hess V.

Ther Umsch. 2008 Apr;65(4):201-5. doi: 10.1024/0040-5930.65.4.201. German.

PMID:
18622911
10.

Doxorubicin followed by docetaxel versus docetaxel followed by doxorubicin in the adjuvant treatment of node positive breast cancer: results of a feasibility study.

Cardoso F, Ferreira Filho AF, Crown J, Dolci S, Paesmans M, Riva A, Di Leo A, Piccart MJ.

Anticancer Res. 2001 Jan-Feb;21(1B):789-95.

PMID:
11299845
11.

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Results of a prospective, randomized, longitudinal trial.

Maruff P, Falleti MG, Collie A.

Cancer. 2004 Nov 1;101(9):2143-4; author reply 2144-5. No abstract available.

12.
13.

[New guidelines for breast cancer focus on information and education. First comes the truth].

Aumiller J.

MMW Fortschr Med. 2009 Jan 15;151(1-2):12-4. German. No abstract available.

PMID:
19227631
14.

Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.

Protière C, Evans K, Camerlo J, d'Ingrado MP, Macquart-Moulin G, Viens P, Maraninchi D, Genre D.

Support Care Cancer. 2002 Oct;10(7):529-37. Epub 2002 Aug 15.

PMID:
12324807
15.

Chemotherapy-induced alopecia.

Duvic M.

South Med J. 1993 Dec;86(12):1446. No abstract available.

PMID:
8272935
16.

Adjuvant docetaxel for node-positive breast cancer.

Ahluwalia MS, Daw HA.

N Engl J Med. 2005 Sep 1;353(9):954-5; author reply 954-5. No abstract available.

17.

Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer.

Puglisi F, Cardellino GG, Crivellari D, Di Loreto C, Magri MD, Minisini AM, Mansutti M, Andreetta C, Russo S, Lombardi D, Perin T, Damante G, Veronesi A.

Ann Oncol. 2008 Sep;19(9):1541-6. doi: 10.1093/annonc/mdn165. Epub 2008 Apr 25.

18.

A randomized trial of minoxidil in chemotherapy-induced alopecia.

Duvic M, Lemak NA, Valero V, Hymes SR, Farmer KL, Hortobagyi GN, Trancik RJ, Bandstra BA, Compton LD.

J Am Acad Dermatol. 1996 Jul;35(1):74-8.

PMID:
8682968
19.

Acute pseudo-obstruction of the small intestine following high-dose chemotherapy and stem cell support.

Bauernhofer T, Eibl M, Ploner F, Kuss I, Pfeifer J, Sill H, Samonigg H.

Onkologie. 2003 Aug;26(4):344-6.

PMID:
12972700
20.

Clinical characteristics of chemotherapy-induced alopecia in childhood.

Choi M, Kim MS, Park SY, Park GH, Jo SJ, Cho KH, Lee JW, Park KD, Shin HY, Kang HJ, Kwon O.

J Am Acad Dermatol. 2014 Mar;70(3):499-505. doi: 10.1016/j.jaad.2013.10.034. Epub 2013 Dec 16.

PMID:
24355411
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk